Ensuring medication adherence with direct oral anticoagulant drugs Lessons from adherence with vitamin K antagonists (VKAs)

被引:39
作者
Di Minno, Alessandro [1 ]
Spadarella, Gaia [2 ]
Tufano, Antonella [2 ]
Prisco, Domenico [3 ]
Di Minno, Giovanni [2 ]
机构
[1] Univ Naples Federico II, Dipartimento Farm, I-80131 Naples, Italy
[2] Univ Naples Federico II, Dipartimento Med Clin & Chirurg, I-80131 Naples, Italy
[3] Univ Florence, Dipartimento Med Sperimentale & Clin, I-50134 Florence, Italy
关键词
Direct oral anticoagulants; Persistence; Communication/cooperation between; patients and doctors; Ex vivo laboratory tests; Patient's awareness; Every day practice; NONVALVULAR ATRIAL-FIBRILLATION; SECONDARY PREVENTION; PATIENT ADHERENCE; RISK-FACTORS; WARFARIN NONADHERENCE; AMBULATORY PATIENTS; IMPROVE ADHERENCE; ELDERLY-PATIENTS; THERAPY; PREDICTORS;
D O I
10.1016/j.thromres.2014.01.016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Medication adherence (taking drugs properly) is uncommon among patients on warfarin. Poor adherence to warfarin leads to an increase in adverse medical events, including stroke in atrial fibrillation (AF). Factors related to patients, physicians and the health system account for poor adherence. Direct oral anticoagulants (DOACs) are easier to use than warfarin, with fewer drug and food interactions and no need for routine blood monitoring. A proper use of DOACs may reduce the risk of stroke in AF. However, in clinical settings where no laboratory monitoring is needed, a poor medication adherence is common and may impact clinical outcomes. In the management of chronic disorders, careful knowledge of the individual patient's attitudes and behaviors is a prerequisite for a successful doctor-patient communication. To increase patient's awareness of the risks and benefits of DOACs and, in turn, increase medication adherence, at each follow-up visit physicians should screen for priorities and motivational problems; check for the lack of understanding and/or knowledge; assess any health system or personal barriers to medication adherence; identify appropriate interventions and provide tailored support to patient needs. Dissemination of guidelines to the health care chain (prescribing physician, general practitioners, caregivers, nurses, pharmacists) further encourages medication adherence. However, the long-term effect of some of these strategies is unknown; one tool may not fit all patients, and the prescribing physician should consider individualization of these aids to ensure medication adherence and persistence (continuing to take drugs properly in long-term treatments) for DOACs in every day practice. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:699 / 704
页数:6
相关论文
共 50 条
  • [31] Determinants and associated factors influencing medication adherence and persistence to oral anticancer drugs: A systematic review
    Verbrugghe, M.
    Verhaeghe, S.
    Lauwaert, K.
    Beeckman, D.
    Van Hecke, A.
    CANCER TREATMENT REVIEWS, 2013, 39 (06) : 610 - 621
  • [32] Evaluation of direct oral anticoagulants and vitamin K antagonists in mesenteric venous thrombosis
    Salim, Saman
    Ekberg, Olle
    Elf, Johan
    Zarrouk, Moncef
    Gottsater, Anders
    Acosta, Stefan
    PHLEBOLOGY, 2019, 34 (03) : 171 - 178
  • [33] Vitamin K antagonists in the era of direct oral anticoagulants: is there still a room for their use?
    Francesco Dentali
    Silvia Galliazzo
    Francesca Zuretti
    Monica Gianni
    Internal and Emergency Medicine, 2017, 12 : 1087 - 1089
  • [34] Vitamin K antagonists in the era of direct oral anticoagulants: is there still a room for their use?
    Dentali, Francesco
    Galliazzo, Silvia
    Zuretti, Francesca
    Gianni, Monica
    INTERNAL AND EMERGENCY MEDICINE, 2017, 12 (08) : 1087 - 1089
  • [35] MT in anticoagulated patients: Direct oral anticoagulants versus vitamin K antagonists
    L'Allinec, Vincent
    Sibon, Igor
    Mazighi, Mikael
    Labreuche, Julien
    Kyheng, Maeva
    Boissier, Elodie
    Roy, Monica
    Gory, Benjamin
    Dargazanli, Cyril
    Desal, Hubert
    Lapergue, Bertrand
    Bourcier, Romain
    NEUROLOGY, 2020, 94 (08) : E842 - E850
  • [36] Differences between patient-driven adherence to vitamin K antagonists and direct oral anticoagulants. Do few missed doses matter? ACO-MEMS Study
    Solla-Ruiz, Itziar
    Villanueva-Benito, Inaki
    Paredes-Galan, Emilio
    Salterain-Gonzalez, Nahikari
    Oria-Gonzalez, Garazi
    De La Cuesta-Arzamendi, Francisco
    Querejeta-Iraola, Ramon
    THROMBOSIS RESEARCH, 2019, 179 : 20 - 27
  • [37] Adequate Adherence to Direct Oral Anticoagulant is Associated with Reduced Ischemic Stroke Severity in Patients with Atrial Fibrillation
    Yamashiro, Kazuo
    Kurita, Naohide
    Tanaka, Ryota
    Ueno, Yuji
    Miyamoto, Nobukazu
    Hira, Kenichiro
    Nakajima, Sho
    Urabe, Takao
    Hattori, Nobutaka
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2019, 28 (06) : 1773 - 1780
  • [38] Assessment of Oral Anticancer Medication Adherence: A Survey from a Tertiary Cancer Center
    Ramachandiran, Balaji
    Dubashi, Biswajit
    Kayal, Smita
    Menon, Vikas
    Yuvaraj, K.
    Deepika, C.
    Francis, Deepa
    Debbarma, Deeksha
    Nair, Devika S.
    SOUTH ASIAN JOURNAL OF CANCER, 2021, 10 (02) : 127 - 130
  • [39] When do patients prefer a direct oral anticoagulant over a vitamin K antagonist?
    Boom, M. S.
    Berghuis, E. M.
    Nieuwkerk, P. T.
    Pinedo, S.
    Bueller, H. R.
    NETHERLANDS JOURNAL OF MEDICINE, 2015, 73 (08) : 368 - 372
  • [40] Adherence and outcomes to direct oral anticoagulants among patients with atrial fibrillation: findings from the veterans health administration
    Borne, Ryan T.
    O'Donnell, Colin
    Turakhia, Mintu P.
    Varosy, Paul D.
    Jackevicius, Cynthia A.
    Marzec, Lucas N.
    Masoudi, Frederick A.
    Hess, Paul L.
    Maddox, Thomas M.
    Ho, P. Michael
    BMC CARDIOVASCULAR DISORDERS, 2017, 17